O

Oncolytics Biotech
ONC

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$61.49M
EV
CA$46.61M
Shares Outstanding
86.60M
Beta
1.51

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
CA$4.69
P/E 2025E
-
P/Revenue 2025E
61.02x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Oncolytics Biotech Inc.

gainify

O

Oncolytics Biotech Inc.

ONC

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in ...

Sector

Healthcare

Industry

Biotechnology

CEO

Pisano, Wayne

Employees

28

IPO Date

2000-06-01

Headquarters

322 11th Avenue SW, Suite 804, Calgary, Alberta, T2R 0C5, Canada

gainify
mailcontactcontact
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.